elafibranor
General
Pronunciation:
el-a-fib-ra-nor
Trade Name(s)
- Iqirvo
Ther. Class.
none assigned
Pharm. Class.
temporary class
peroxisome proliferator-activated receptor agonistThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Elafibranor." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580120/11/elafibranor.
Vallerand AHA, Sanoski CAC. Elafibranor. Davis's Drug Guide. F.A. Davis Company; 2026. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580120/11/elafibranor. Accessed June 28, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Elafibranor. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580120/11/elafibranor
Vallerand AHA, Sanoski CAC. Elafibranor [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 28]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580120/11/elafibranor.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - elafibranor
ID - 3580120
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580120/11/elafibranor
PB - F.A. Davis Company
ET - 20
DB - Nursing Central
DP - Unbound Medicine
ER -

Davis's Drug Guide

